James Davidson Finklea Jr. MD
Critical Care Medicine, Pleural Disease
Assistant Professor, Internal Medicine, University of Texas Southwestern Medical Center
Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-0599
Fax+1 214-645-3297
Dr. Finklea is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2012
Baylor Scott & White Medical Center - Baylor College of Medicine (Temple)Residency, Internal Medicine, 2006 - 2009
John Peter Smith Hospital (Tarrant County Hospital District)Residency, Family Medicine, 2004 - 2006
University of Texas Medical Branch School of MedicineClass of 2004
Certifications & Licensure
AR State Medical License 2023 - 2025
OK State Medical License 2022 - 2025
TX State Medical License 2008 - 2025
GA State Medical License 2009 - 2012
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Cefiderocol pharmacokinetics during acute pulmonary exacerbations in hospitalized adult persons with cystic fibrosis.Christina Koenig, Marguerite L Monogue, Ryan K Shields, Colleen M Sakon, Andrew J Fratoni
Antimicrobial Agents and Chemotherapy. 2025-01-31 - 1 citationsDevelopment of metabolic syndrome in people with Cystic Fibrosis one year after exposure to elexacaftor-tezacaftor-ivacaftor.Gregory A Ratti, Hannah Smith, Sasan Mirfakhraee, Joan Reisch, Leah Cohen
Journal of Cystic Fibrosis. 2025-01-01 - 1 citationsGenomic epidemiology ofat an adult cystic fibrosis programme reveals low potential for healthcare-associated transmission.Jane E Gross, James D Finklea, Silvia M Caceres, Katie R Poch, Nabeeh A Hasan
ERJ Open Research. 2024-07-01
Journal Articles
- Antimicrobial Susceptibility Study Ceftolozane/tazobactam Sensitivity Patterns in Pseudomonas Aeruginosa Isolates Recovered from Sputum of Cystic Fibrosis PatientsJames D Finklea, Raksha Jain, Karen Lowe, Francesca Lee, ScienceDirect
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
